UPTAKE OF NEWER SECOND-LINE DIABETES MEDICATIONS IN REAL-WORLD VULNERABLE POPULATIONS

被引：0
|
作者：
Ogunsanmi, D. [1 ]
Harrison, A. T. [2 ]
Kovesdy, C. P. [1 ]
Surbhi, S. [1 ]
机构：
[1] Univ Tennessee, Hlth Sci Ctr, Memphis, TN 38163 USA
[2] Rhodes Coll, Memphis, TN 38112 USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HSD112
引用
收藏
页码：S499 / S499
页数：1
相关论文
共 50 条
  • [1] Second-Line Therapy for Immune Thrombocytopenia: Real-World Experience
    Nazaryan, Hasmik
    Liu, Yang
    Sirotich, Emily
    Duncan, Joanne M.
    Arnold, Donald M.
    BLOOD, 2019, 134
  • [2] Use of real-world evidence data to evaluate the comparative effectiveness of second-line type 2 diabetes medications on chronic kidney disease
    Deng, Yu
    Ghamsari, Farhad
    Lu, Alice
    Yu, Jingzhi
    Zhao, Lihui
    Kho, Abel N.
    JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY, 2022, 30
  • [3] Relationship between Diabetes Duration and Real-World Effectiveness of Second-Line Dual OAD Therapy
    Brath, Helmut
    Paldanius, Paeivi M.
    Bader, Giovanni
    Mathieu, Chantal
    DIABETES, 2015, 64 : A315 - A316
  • [4] The real-world effectiveness of intravenous brivaracetam as a second-line treatment in status epilepticus
    Martellino, Chiara
    Lagana, Angelina
    Atanasio, Giorgia
    Lamanna, Fabio
    Attardo, Silvia
    Cascino, Simona
    De Luca, Marcella
    Pardeo, Orazio
    Giacobbe, Giuseppa
    Tripepi, Giovanni
    Roberti, Roberta
    Granata, Francesca
    Morace, Carmela
    Russo, Emilio
    Labate, Angelo
    EPILEPSY & BEHAVIOR, 2023, 148
  • [5] Cardiovascular events associated with second-line anti-diabetes treatments: analysis of real-world Korean data
    Ha, K. H.
    Kim, B.
    Choi, H.
    Kim, D. J.
    Kim, H. C.
    DIABETIC MEDICINE, 2017, 34 (09) : 1235 - 1243
  • [6] Comparative Effectiveness of Second-Line Glucose-Lowering Medications-Emulation of a Target Trial Using Real-World Data
    Deng, Yihong
    Polley, Eric
    Wallach, Joshua D.
    Herrin, Jeph
    Ross, Joseph
    McCoy, Rozalina G.
    DIABETES, 2023, 72
  • [7] Persistence of newer anti-obesity medications in a real-world setting
    Ganguly, Rahul
    Tian, Ye
    Kong, Sheldon X.
    Hersloev, Malene
    Hobbs, Todd
    Smolarz, B. Gabriel
    Ramasamy, Abhilasha
    Haase, Christiane Lundegaard
    Weng, Wayne
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 143 : 348 - 356
  • [8] Real-world weight loss with diabetes medications: But is it actually real?
    Elmes, Abigail T.
    Jarrett, Jennie B.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2022, 62 (01) : 27 - 27
  • [9] Real-world outcomes upon second-line treatment in patients with chronic lymphocytic leukaemia
    Vainer, Noomi
    Aarup, Kathrine
    Andersen, Michael Asger
    Wind-Hansen, Lise
    Nielsen, Tine
    Frederiksen, Henrik
    Enggaard, Lisbeth
    Poulsen, Christian Bjorn
    Niemann, Carsten U.
    Rotbain, Emelie C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 (05) : 874 - 886
  • [10] Second-line metastatic urothelial carcinoma treatment and survival in real-world patients in the US
    Pal, S. K.
    Galsky, M. D.
    Lin, S-W.
    Ogale, S.
    Zivkovic, M.
    Simpson, J.
    Derleth, C.
    Sonpavde, G.
    ANNALS OF ONCOLOGY, 2016, 27
12345